Linc AB Overview
Founded in 1991 and headquartered in Stockholm, Sweden, Linc AB focuses on long-term investments in small and medium-sized product-oriented companies within the medical technology and pharmaceutical industries. The firm invests in both private and public companies, as well as in research and operational entities. Typically, investments in pharmaceutical companies occur at an early stage, while investments in medical technology companies are made in more mature businesses. Linc AB is an active owner, contributing capital, expertise, experience, and networks to support the development of its portfolio companies.
Is Linc AB the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Linc AB, along with a list of other relevant VCs, is available on Hopohopo.io.
Linc AB
Investment focus
Invest in
- Nordics
Product type
- Hardware
- Drugs / Pharma
Industries / verticals
- BioTech & Life Sciences
- MedTech & Devices
- PharmaTech
Stages
Pre-seed, Seed, Series A, Series B or later
First ticket size
SEK 25,000,000 - SEK 250,000,000
How to approach funds like Linc AB
When approaching Linc AB, founders should highlight how their company’s product addresses a clear market need within the medical technology or pharmaceutical sectors, and demonstrate a path to sustainable growth. Emphasize your team’s technical expertise and ability to execute, as well as any traction or validation that signals readiness for active partnership. Linc values founders who are open to hands-on collaboration and can articulate how Linc’s operational involvement and network will accelerate their company’s development.
Find the best-fitting investors for your startup
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.
